Sector
1063 stories · page 52 of 54
The 30-patient study is designed to test the hypothesis that a combination of injected leronlimab and regorafenib taken orally will increase progression-free survival in patients with CCR5-positive metastatic colorectal cancer
Based on the Phase 1 study results, the company said that a new Phase 2 recurrent ovarian cancer clinical study has already begun at the University of Pittsburgh Medical Center
Senior research analyst Nina Deka says the Netherlands-based company has four new platforms to go after a $4 billion market opportunity
The SugarBEAT works for patients with diabetes or prediabetes by testing their blood glucose levels using a sensor on the skin, rather than using a needle
The updates were provided alongside the company's interim results
ZilosulÒ (iPPS) is a potential first-line therapeutic treatment for osteoarthritis and other diseases affecting the musculoskeletal system.
The firm's sustained-release Sol-Gel (soluble gel) program allows for the nasal delivery of medical compounds, including cannabinoids like CBD
Recent trial results support the view that the drug could be an effective bronchodilator in COPD patients via various delivery methods
The company has a cash pile of $88.7 million to fund operations and reach clinical milestones in the first half of 2020
The cash will allow the company to continue clinical development of its lead cancer drug and provide working capital while a partner is sought
XPhyto’s CEO Hugh Rogers shares his unique insights on taking a scientific approach to cannabis, bridging the gap between medical marijuana and clinical validation and why the company - which has floated on the CSE today - focused on German
A first patient is being treated under emergency investigational new drug regulations of the US Food and Drug Administration
The company said it also expects to receive a tax credit shortly
The FTSE 100 has fallen around 5% since the start of the month
Avangen is engaged in the development and sale of clinically validated anti-ageing products for skin, hair and body.
newtec testnewtec testnewtec testnewtec testnewtec testnewtec testnewtec test
Obalon is launching a $3 million direct offering in a common move to take advantage of Wednesday's massive rally
CEO Taylor J Crouch says preclinical development of 3D-bioprinted tissues will extend into calendar 2020
The San Diego company says average weight loss for patients receiving three balloons and six months of therapy was nearly 22 pounds
Judges Scientific PLC (LON:JDG) posted strong 2018 full year results with revenues at £77.9mln (9% up year-on-year, including 5.5% organic growth) and adjusted operating profit at £14.7mln (35% up year-on-year). Revenue growth was solid acr